Efficacy and safety of apatinib for the treatment of extensive-stage small cell lung cancer in Chinese patients: a single-arm systematic review and meta-analysis
Apatinib has shown promising efficacy and tolerability in the treatment of ES-SCLC. Compared with monotherapy, apatinib combined with chemotherapy or immunotherapy may offer enhanced therapeutic benefits.
Authors
- Tingting Nan
- Xianni Wei
- J. Y. Wei
- Siheng Lian
- Yumei Cai
- Ruina Cai
- Xiaohong Wu
- Xiaoyun Ye
- Yonglong Su
Institutions
- Xiamen Chang Gung Hospital (CN)
Publication Details
- Journal
- Chinese Clinical Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.21037/cco-25-34
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00